Equities

Parenteral Drugs (India) Ltd

Parenteral Drugs (India) Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)2.90
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Aug 21 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2022202220212020
OPERATIONS
Net income(1091)(1545)(1417)
Depreciation/depletion401173173
Non-Cash items5501,2641,105
Cash taxes paid, supplemental000
Cash interest paid, supplemental1,0621,2541,100
Changes in working capital1351,3601,262
Total cash from operations(4.83)1,2531,124
INVESTING
Capital expenditures------
Other investing and cash flow items, total6470.620.79
Total cash from investing6470.620.79
FINANCING
Financing cash flow items(994)(1254)(1100)
Total cash dividends paid------
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net3510.01(25)
Total cash from financing(643)(1254)(1124)
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash(0.57)(0.51)0.13
Net cash-begin balance/reserved for future use0.571.080.95
Net cash-end balance/reserved for future use0.000.571.08
SUPPLEMENTAL INCOME
Depreciation, supplemental401173173
Cash interest paid, supplemental1,0621,2541,100
Cash taxes paid, supplemental000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.